Ultragenyx Pharmaceutical, Inc. (RARE)

110.88
NASDAQ
Prev Close 106.71
Day Low/High 106.76 / 111.85
52 Wk Low/High 62.34 / 179.65
Exchange NASDAQ
Shares Outstanding 67.48B
Market Cap 7.20B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

Arcturus Therapeutics Has a Candidate for a Covid-19 Vaccine

When I first started buying ARCT shares I didn't conceive of a valuation of $1 billion, but I also didn't conceive of the global impact of a pandemic.

This Market Is Green

Indices have not changed much since my last post and the market remains solidly in the green. Not a big rise, but a steady one. Strength in the market continues to be mostly in the small cap names as it has for most of the last week. The Russell 200...

Electric Car Stocks Get a Charge as Pockets of Momentum Develop

Electric Car Stocks Get a Charge as Pockets of Momentum Develop

When the indices aren't offering much opportunity money flows into individual speculative names.

Three Biotech Names to Consider

Three Biotech Names to Consider

A look at three names to consider in the biotech and biopharma space.

Ironwood Jumps on Phase 2a Data; Ultragenyx Climbs -- Biotech Movers

Ironwood Jumps on Phase 2a Data; Ultragenyx Climbs -- Biotech Movers

The Cambridge, Mass.-based Ironwood unveiled top-line data from a pair of Phase 2a studies evaluating IW-1973 in patients that have type 2 diabetes and hypertension.

Where the Money Was Made the Last 5 Years

Where the Money Was Made the Last 5 Years

Only one fund category (of 20) has beaten the S&P 500 over half a decade.